ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,811Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 240

$1.28M Total Retail Price of All Prescriptions

Rank: 2 out of 240

347 Patients Receiving at Least One Drug in Part D
13%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 347 patients filled at least one prescription for a schedule two drug, compared to an average of 13%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

5% of this provider’s 774 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$146 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
ZOLPIDEM TARTRATE 384 30 1 33
BUPROPION XL 383 60 2 61
TRAZODONE HCL 366 0 3 29
SERTRALINE HCL 356 47 4 20
ABILIFY 323 17 5 49
RISPERIDONE 315 58 6 40
QUETIAPINE FUMARATE 295 16 7 38
VENLAFAXINE HCL ER 275 60 8 48
LAMOTRIGINE 274 38 9 54
CYMBALTA 265 18 10 47
CLOZAPINE 224 0 11 56
ESCITALOPRAM OXALATE 207 20 12 99
BENZTROPINE MESYLATE 198 21 R 13 88
BUSPIRONE HCL 189 13 14 102
FLUOXETINE HCL 166 23 15 57
MIRTAZAPINE 164 39 16 22
DIVALPROEX SODIUM ER 163 15 17 78
OXCARBAZEPINE 161 0 18 114
CITALOPRAM HBR 159 21 19 18
OLANZAPINE 146 12 20 82
TOPIRAMATE 141 0 21 58
PAROXETINE HCL 129 12 22 63
SEROQUEL 116 0 23 98
HYDROXYZINE PAMOATE 114 0 R 24 109
DEXTROAMPHETAMINE SULFATE 111 0 S2 10 25 143
LITHIUM CARBONATE 109 0 26 145
DOXEPIN HCL 109 0 26 145
GABAPENTIN 107 23 28 15
RISPERDAL CONSTA 106 0 29 150
AMPHETAMINE SALT COMBO 105 0 S2 30 151
DIVALPROEX SODIUM 101 0 31 71
INVEGA SUSTENNA 97 12 32 154
STRATTERA 93 0 10 33 156
ZALEPLON 88 0 34 160
ZIPRASIDONE HCL 87 0 35 106
DEXTROAMPHETAMINE-AMPHETAMINE 87 0 S2 35 163
FAZACLO 85 0 37 165
PRISTIQ ER 80 0 38 168
BUPROPION HCL SR 80 0 38 104
THIOTHIXENE 71 0 40 174
TRIHEXYPHENIDYL HCL 60 0 R 41 190
PERPHENAZINE 60 0 41 190
LEXAPRO 60 0 41 190
LUNESTA 57 0 44 194
HALOPERIDOL DECANOATE 56 0 45 197
HALOPERIDOL 56 0 45 136
HYDROXYZINE HCL 54 20 R 47 204
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 30, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.